Cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug
Abstract Background Cannabidiol (CBD) extracted from the cannabis plant is believed to have a medicinal value due to its neuroprotective effect via anti-inflammatory and antioxidant action. Recent behavioral studies in rats have reported that CBD mediates serotonin (5-HT1A) receptor action to improv...
Main Authors: | Akihiro Hasumi, Hideyuki Maeda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Journal of Cannabis Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42238-023-00177-w |
Similar Items
-
Standardized Method for the Assessment of Behavioral Responses of Zebrafish Larvae
by: Hideyuki Maeda, et al.
Published: (2021-07-01) -
The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
by: Martina Rabino, et al.
Published: (2021-09-01) -
Comparison between haloperidol decanoate and oral haloperidol on seeking psychiatric emergency care
by: L. Osaku, et al.
Published: (2022-06-01) -
Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A<sub>2A</sub> Receptor
by: Iu Raïch, et al.
Published: (2023-12-01) -
Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
by: Elena E. Vaiman, et al.
Published: (2021-07-01)